ReviewRSC advances2025
Research progress on the preparation, performance, mechanisms, and applications of carbon nanomaterials against Gram-negative bacteria.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antifungal Efficacy of Carbon Quantum Dots Combined with Photodynamic Therapy AgainstFoods (Basel, Switzerland) · 2026Article
- Food processing-derived carbon dots disrupt male fertility via the gut-testis axis.Science China. Life sciences · 2026Article
- A comprehensive review of carbon dots for antimicrobial therapy: from design mechanisms to theranostic applications.Discover nano · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The excessive and inappropriate use of antibiotics in clinical settings has led to bacterial mutations and the emergence of drug resistance. This escalating problem presents a major challenge in the treatment of infections, particularly those caused by Gram-negative and multidrug-resistant bacteria, for which effective therapeutic options are increasingly limited. As a result, there is an urgent need to develop novel antimicrobial agents. Recent studies have demonstrated that carbon nanomaterials, owing to their potent antibacterial activity and low susceptibility to resistance, are emerging as promising candidates in antimicrobial research. This review provides a comprehensive overview of recent advancements in the synthesis strategies, antibacterial efficacy against Gram-negative bacteria, underlying antimicrobial mechanisms, and biomedical applications of four main carbon nanomaterials (CNMs) of graphene quantum dots (GQDs), carbon dots (CDs), carbon nanotubes (CNTs), and graphene. The preparation methods and antibacterial mechanisms of CNMs with antibacterial properties are the main section. Additionally, the review addresses the current challenges hindering their clinical translation and explores potential future directions with a focus on efficacy and safety. By collating current findings, this review aims to establish a theoretical foundation for the development of innovative antimicrobial agents targeting Gram-negative bacteria.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.